We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Trial Data May Delay Lipitor Follow-On, Analyst Says
Trial Data May Delay Lipitor Follow-On, Analyst Says
November 18, 2005
Mixed results from two Phase II clinical trials could delay Pfizer’s launch of its next-generation Lipitor product by as long as two years, according to a Wall Street analyst.